Consensus Rallybio Corporation

Equities

RLYB

US75120L1008

Market Closed - Nasdaq Other stock markets 16:30:01 2024-05-03 EDT			5-day change	1st Jan Change
1.83 ^USD	0.00%		+7.65%	-23.43%

04-17	Ralebio Corporation Announces the Presentation of Results from FNAIT Systematic Literature Review and Meta- Analysis At the Academy of Managed Care Pharmacy 2024 Annual Meeting	CI
04-12	Top Premarket Decliners	MT

Evolution of the average Target Price on Rallybio Corporation

Price target over the last 5 years

History of analyst recommendation changes

f.AG8oH4CkTywKaBkB8-liMM_OQj1xxSnfU0quhE76_ck.Typ7XbHdHkdNWFA5ittRUqv8L3gbkQSLaxmfxgORk_xYQk5lsM4adUVbIQ~83c9be41dd3f19b8fc3514259c7ec783

Analyst Recommendations on Rallybio Corporation

Wedbush Lowers Rallybio's PT to $11 From $13 After Private Placement, Adjusts Full-Year 2024 Share Count; Maintains Outperform Rating	04-11	MT
HC Wainwright Cuts Rallybio Price Target to $9 From $12, Maintains Buy Rating	03-13	MT
JMP Securities Adjusts Price Target on Rallybio to $8 From $16, Maintains Market Outperform Rating	02-07	MT
Wedbush Adjusts Rallybio's Price Target to $13 From $14, Keeps Outperform Rating	02-07	MT
Jefferies Downgrades Rallybio to Hold From Buy, Adjusts Price Target to $1.50 From $7	02-07	MT
Evercore ISI Cuts Price Target on Rallybio to $15 From $18, Maintains Outperform Rating	12-21	MT
HC Wainwright Trims Rallybio Price Target to $17 From $18, Maintains Buy Rating	11-10	MT
Wedbush Lowers Rallybio's PT to $14 From $16, Retains Cash Runway Guidance But Increases Discount Rate; Maintains Outperform Rating	11-10	MT
JMP Securities Adjusts Price Target on Rallybio to $16 From $26, Maintains Market Outperform Rating	23-06-26	MT
Wedbush Trims Rallybio Price Target to $16 From $17, Maintains Outperform Rating	23-05-09	MT
HC Wainwright Starts Rallybio at Buy With $18 Price Target	23-04-17	MT
Wedbush Starts Rallybio at Outperform With $17 Price Target, Sees 'Favorable' Risk/Reward Setup	23-04-10	MT
JPMorgan Starts Rallybio at Overweight With $21 Price Target	22-12-09	MT
JMP Securities Increases Rallybio's Price Target to $34 From $29, Keeps Market Outperform Rating	22-08-09	MT
JMP Securities Raises Rallybio's Price Target to $34 From $29, Maintains Market Outperform Rating	22-08-09	MT
JMP Securities Adjusts Rallybio's Price Target to $29 From $32, Keeps Market Outperform Rating	22-03-16	MT
JonesTrading Initiates Rallybio at Buy with $30 Price Target	22-03-07	MT
JMP Securities Initiates Rallybio at Market Outperform With $32 Price Target	22-02-22	MT
RALLYBIO : Evercore ISI Initiates Coverage on Rallybio With Outperform Rating, $40 Price Target	21-08-23	MT
RALLYBIO : Cowen Initiates Coverage on Rallybio With Outperform Rating	21-08-23	MT
RALLYBIO : Jefferies Starts Rallybio at Buy With $20 Price Target	21-08-23	MT